Search Within

William K Kelly

Formats
  1. Journal Article (82)
  2. Meeting Abstract (25)
  3. Book Section (6)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (84)
  2. Solid Tumor Oncology Division (82)
  3. Genitourinary Oncology Service (81)
  4. Hematologic Malignancies, Division of (34)
  5. Nursing (31)
  6. GSK Faculty (24)

More Groups

People
  1. Howard Scher (76)
  2. Susan Slovin (31)
  3. Michael Morris (24)
  4. Tracy Smart-Curley (23)
  5. Lawrence Schwartz (20)
  6. Paul Marks (16)

More People

Years
  1. 2017 (1)
  2. 2016 (1)
  3. 2009 (2)
  4. 2007 (4)
  5. 2006 (4)
  6. 2005 (21)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Clinical Cancer Research (13)
  3. Urology (13)
  4. Cancer (9)
  5. Journal of Urology (5)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Elsevier Science, Inc. (20)
  3. American Association for Cancer Research (16)
  4. Elsevier Inc. (9)
  5. Wiley Blackwell (9)
  6. Lippincott Williams & Wilkins (4)

More Publishers

Results (115)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Use of nomograms for predicting survival in patients with castrate prostate cancer
    Journal Article

    Galsky, M.; Kelly, W. K.
    Urology (2003)

    Fulltext@MSK | Save
  • Estimating survival benefit in castrate metastatic prostate cancer: Decision making in proceeding to a definitive phase III trial
    Journal Article

    Verbel, D. A.; Kelly, W. K.; Smaletz, O.; Regan, K.; Curley, T.; Heller, G.; Scher, H. I.
    Urology (2003)

    Fulltext@MSK | Save
  • Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma
    Journal Article

    Solit, D. B.; Morris, M.; Slovin, S.; Curley, T.; Schwartz, L.; Larson, S.; Kattan, M. W.; Hartley-Asp, B.; Scher, H. I.; Kelly, W. K.
    Cancer (2003)

    Fulltext@MSK | Save
  • Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castration
    Journal Article

    Smaletz, O.; Galsky, M.; Scher, H. I.; Delacruz, A.; Slovin, S. F.; Morris, M. J.; Solit, D. B.; Davar, U.; Schwartz, L.; Kelly, W. K.
    Annals of Oncology (2003)

    Fulltext@MSK | Save
  • A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813
    Journal Article

    Oh, W. K.; Halabi, S.; Kelly, W. K.; Werner, C.; Godley, P. A.; Vogelzang, N. J.; Small, E. J.
    Cancer (2003)

    Fulltext@MSK | Save
  • Dose escalation study of intravenous estramustine phosphate in combination with paclitaxel and carboplatin in patients with advanced prostate cancer
    Journal Article

    Kelly, W. K.; Zhu, A. X.; Scher, H.; Curley, T.; Fallon, M.; Slovin, S.; Schwartz, L.; Larson, S.; Tong, W.; Hartley-Asp, B.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Phase I clinical trial of histone deacetylase inhibitor: Suberoylanilide hydroxamic acid administered intravenously
    Journal Article

    Kelly, Wm K.; Richon, V. M.; O'connor, O.; Curley, T.; Macgregor-Cortelli, B.; Tong, W.; Klang, M.; Schwartz, L.; Richardson, S.; Rosa, E.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Chemotherapy for androgen-independent prostate cancer
    Book Section

    Solit, D. B.; Kelly, W. K.
    In Kantoff, P. W.; Carroll, P. R.; D'Amico, A. V. (Eds.) Prostate Cancer: Principles & Practice. 1st ed (2002)

    Fulltext@MSK | Save
  • A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)
    Meeting Abstract

    Kelly, W.; O'connor, O.; Richon, V. M.; Tong, W.; Rao, T. D.; Chiao, J.; O'Brien, J. P.; Rifkind, R. A.; Marks, P. A.; Scher, H. I.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • Clinical experience of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in heavily pre-treated patients with aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)
    Meeting Abstract

    O'Connor, O. A.; Richon, V.; Moskowitz, C. H.; Zelenetz, A. D.; Macgregor-Cortelli, B.; Curly, T.; Richardson, S.; Tong, W.; Rifkind, R.; Marks, P.; more...
    Blood (2002)

    Fulltext@MSK | Save